Making Circulating Cancer Cells visible and avoiding unnesessary biopsies with a single blood draw.

CHALLENGE

Tissue biopsies provide the basis for thousands of treatment decisions every day. Yet, in over 50% of cases patients turn out not to have cancer. The biopsy was unnecessary. Healthy individuals may experience pain, risk complications and incur significant costs.

TECHNOLOGY

Cancer sheds at least three different types of tumor cells into the blood circulation^1,2. XZELL developed a simple blood test to detect all types of circulating tumor cells^3,4,5,6. Presence of cells indicates cancer, while absence of cells rules out cancer with nearly 100% accuracy.

APPLICATION

Urologists in Thailand, Singapore and other ASEAN countries are now able to use X-ZELL’s ground-breaking, patented technology as a diagnostic tool to detect prostate-derived tumor cells, as proven in a series of clinical studies involving more than 250 patients and healthy controls.

Removing all healthy blood cells and exposing cancer cells.

The average cancer cell is hiding between five billion blood cells. Our patents cover technologies to remove 99.999998% of all healthy cells, while preserving eight out of 10 cancer cells. Cell analysis is performed under the microscope. Results are reported by board-certified medical specialists.